Key points are not available for this paper at this time.
Despite evidence that guideline-directed medical therapies (GDMTs) improve outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF), implementation remains suboptimal.
Margolin et al. (Wed,) studied this question.